Use of nanosystems to improve the anticancer effects of curcumin

• Andrea M. Araya-Sibaja,
• Norma J. Salazar-López,
• Krissia Wilhelm Romero,
• José R. Vega-Baudrit,
• J. Abraham Domínguez-Avila,
• Carlos A. Velázquez Contreras,
• Ramón E. Robles-Zepeda,
• Mirtha Navarro-Hoyos and
• Gustavo A. González-Aguilar

Beilstein J. Nanotechnol. 2021, 12, 1047–1062, doi:10.3762/bjnano.12.78

• constituted by lipophilic and hydrophilic polymers which contribute to increase their systemic mobility and residence time [86]. The advantages of this hybrid system include high encapsulation efficiency, well-defined release kinetics, well-tolerated serum stability, and well-triggered tissue, cellular, and

Comprehensive review on ultrasound-responsive theranostic nanomaterials: mechanisms, structures and medical applications

• Sepand Tehrani Fateh,
• Lida Moradi,
• Elmira Kohan,
• Michael R. Hamblin and
• Amin Shiralizadeh Dezfuli

Beilstein J. Nanotechnol. 2021, 12, 808–862, doi:10.3762/bjnano.12.64

Plant growth regulation by seed coating with films of alginate and auxin-intercalated layered double hydroxides

• Vander A. de Castro,
• Valber G. O. Duarte,
• Danúbia A. C. Nobre,
• Geraldo H. Silva,
• Vera R. L. Constantino,
• Frederico G. Pinto,
• Willian R. Macedo and
• Jairo Tronto

Beilstein J. Nanotechnol. 2020, 11, 1082–1091, doi:10.3762/bjnano.11.93

• the stacking of particles in the form of plates (Figure 4a,b). The ZnAl-NAA-LDH sample exhibits a surface in the form of compact plates (Figure 4c,d). In vitro experiments to prove the efficiency of ZnAl-NAA-LDH as a slow-release matrix were performed in solutions with pH 4 and pH 7, and the release

• kinetics was also studied. See Supporting Information File 1 for complete experimental data. Germination rate and germination speed index The seed germination rate results are shown in Figure 5. After the final germination period of 15 days, the control experiment showed the highest percentage of

Luminescent gold nanoclusters for bioimaging applications

• Nonappa

Beilstein J. Nanotechnol. 2020, 11, 533–546, doi:10.3762/bjnano.11.42

• endocytosis. The superparamagnetic nature of the PML-MF allowed for the magnetic targeting of the nanocarriers. Further, the ability of BSA to encapsulate drug molecules was explored to load doxorubicin (DPML-MF) in the nanocarriers. The release kinetics of doxorubicin studied at pH 7.4 and 4.4 were found to

Fully amino acid-based hydrogel as potential scaffold for cell culturing and drug delivery

• Dávid Juriga,
• Evelin Sipos,
• Orsolya Hegedűs,
• Gábor Varga,
• Miklós Zrínyi,
• Krisztina S. Nagy and
• Angéla Jedlovszky-Hajdú

Beilstein J. Nanotechnol. 2019, 10, 2579–2593, doi:10.3762/bjnano.10.249

• established. Using metoprolol as a model drug, cell proliferation and drug release kinetics were studied at different LYS contents and in the presence of thiol groups. The optimal ratio of cross-linkers for the proliferation of periodontal ligament cells was found to be 60−80% LYS and 20−40% CYS. The

• well as biocompatibility and biodegradability are also fundamental features of polymers developed for numerous medical applications [11][12]. Polymer hydrogels are capable of releasing physically entrapped drug molecules. The release kinetics of the loaded drug molecules depend significantly on the

• improve the pharmacological and therapeutic properties of various drugs [28]. By applying such microcarriers, the drug release kinetics can be controlled. Among the anionic amino acids, glutamic acid was previously used for the preparation of polymer-based microcarriers [33]. However, there are only

Design of a nanostructured mucoadhesive system containing curcumin for buccal application: from physicochemical to biological aspects

• Sabrina Barbosa de Souza Ferreira,
• Gustavo Braga,
• Évelin Lemos Oliveira,
• Jéssica Bassi da Silva,
• Hélen Cássia Rosseto,
• Lidiane Vizioli de Castro Hoshino,
• Mauro Luciano Baesso,
• Wilker Caetano,
• Craig Murdoch,
• Helen Elizabeth Colley and
• Marcos Luciano Bruschi

Beilstein J. Nanotechnol. 2019, 10, 2304–2328, doi:10.3762/bjnano.10.222

• used to evaluate the release mechanism of CUR. Here, the release exponent (n), which determines if the drug release mechanism is Fickian (Case I) or non-Fickian (transport Case II, anomalous or super case II) revealed an n value of 0.6517. The nanostructured systems displayed anomalous release kinetics

Incorporation of doxorubicin in different polymer nanoparticles and their anticancer activity

• Sebastian Pieper,
• Hannah Onafuye,
• Dennis Mulac,
• Jindrich Cinatl Jr.,
• Mark N. Wass,
• Martin Michaelis and
• Klaus Langer

Beilstein J. Nanotechnol. 2019, 10, 2062–2072, doi:10.3762/bjnano.10.201

• preparation by solvent displacement led to the smallest nanoparticles. In PLGA nanoparticles, the drug load could be optimised using solvent displacement at pH 7 reaching 53 µg doxorubicin/mg nanoparticle. These PLGA nanoparticles displayed sustained doxorubicin release kinetics compared to the more burst

• -like kinetics of the other preparations. In neuroblastoma cells, doxorubicin-loaded PLGA-PEG nanoparticles (presumably due to their small size) and PLGA nanoparticles prepared by solvent displacement at pH 7 (presumably due to their high drug load and superior drug release kinetics) exerted the

• [50]. To optimise the loading efficiency and drug release kinetics of PLGA nanoparticles the pH value of the stabiliser solution used during nanoparticle preparation was increased to 7. At this pH value, doxorubicin exists in the more lipophilic deprotonated form [51]. The use of PVA solution at pH 7

Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells

• Hannah Onafuye,
• Sebastian Pieper,
• Dennis Mulac,
• Jindrich Cinatl Jr.,
• Mark N. Wass,
• Klaus Langer and
• Martin Michaelis

Beilstein J. Nanotechnol. 2019, 10, 1707–1715, doi:10.3762/bjnano.10.166

• paclitaxel with albumin may differ from that of doxorubicin. Hence, variations in drug binding and drug release kinetics may be responsible for this difference. Despite the prominent role of ABCB1 as a drug resistance mechanism, attempts to exploit it as drug target have failed so far, despite the

Layered double hydroxide/sepiolite hybrid nanoarchitectures for the controlled release of herbicides

• Ediana Paula Rebitski,
• Margarita Darder and
• Pilar Aranda

Beilstein J. Nanotechnol. 2019, 10, 1679–1690, doi:10.3762/bjnano.10.163

• , producing stable systems even using consolidation temperatures as low as 60 °C. The developed hybrid nanoarchitectures have been tested in vitro as systems for the controlled release of the incorporated organic species MCPA. In vitro tests carried out in deionized water showed that the herbicide release

• kinetics depended on the nanoarchitecture composition and the method of preparation. The materials with higher LHD content showed slower release rates. The herbicide could be completely released from the hybrid nanoarchitectures, confirming their suitability for the controlled release of pesticides in

Biomimetic and biodegradable cellulose acetate scaffolds loaded with dexamethasone for bone implants

• Aikaterini-Rafailia Tsiapla,
• Varvara Karagkiozaki,
• Veroniki Bakola,
• Foteini Pappa,
• Panagiota Gkertsiou,
• Eleni Pavlidou and
• Stergios Logothetidis

Beilstein J. Nanotechnol. 2018, 9, 1986–1994, doi:10.3762/bjnano.9.189

• . Cytotoxicity studies were performed by using MTT assay, methylene-blue staining and SEM fixation and showed very good cell adhesion and proliferation, indicating the cytocompatibility of these fibrous scaffolds. Drug-release kinetics was measured for the evaluation of a controllable and sustained release of

• is created [23]. Grounded aluminum foils, glass substrates and also coatings for orthopaedic pins were used as collectors to carry out the necessary studies. Drug-release kinetics and degradation study of scaffolds Degradation study was carried out in order to evaluate the mass loss of polymer and

• study was examined in both pure CA and drug-loaded CA scaffolds over a period of 150 days to determine how the degradation rate is affected by the presence of the drug. Finally, release kinetics of drug-loaded CA electrospun scaffolds was measured. Degradation study: First, the electrospun samples were

BN/Ag hybrid nanomaterials with petal-like surfaces as catalysts and antibacterial agents

• Konstantin L. Firestein,
• Denis V. Leybo,
• Alexander E. Steinman,
• Andrey M. Kovalskii,
• Andrei T. Matveev,
• Anton M. Manakhov,
• Irina V. Sukhorukova,
• Pavel V. Slukin,
• Nadezda K. Fursova,
• Sergey G. Ignatov,
• Dmitri V. Golberg and
• Dmitry V. Shtansky

Beilstein J. Nanotechnol. 2018, 9, 250–261, doi:10.3762/bjnano.9.27

• /Ag HNMs obtained via CVD and UV decomposition of AgNO3. Both samples demonstrated a sustained ion release over 14 days and similar ion release kinetics. During the first 3 h, approximately 25 ppb of Ag+ ions were released, after this, the Ag+ ion leaching gradually slowed down. The average rate of Ag

Chitosan-based nanoparticles for improved anticancer efficacy and bioavailability of mifepristone

• Huijuan Zhang,
• Fuqiang Wu,
• Yazhen Li,
• Xiping Yang,
• Jiamei Huang,
• Tingting Lv,
• Yingying Zhang,
• Jianzhong Chen,
• Haijun Chen,
• Yu Gao,
• Guannan Liu and
• Lee Jia

Beilstein J. Nanotechnol. 2016, 7, 1861–1870, doi:10.3762/bjnano.7.178

• loading capacity (DL). MCNs prepared with the optimum conditions resulted in spherical particles with an average size of 200 nm. FTIR and XRD spectra verified that MIF was successfully encapsulated in CNs. The EE and DL of MCNs determined by HPLC were 86.6% and 43.3%, respectively. The in vitro release

• kinetics demonstrated that MIF was released from CNs in a sustained-release manner. Compared with free MIF, MCNs demonstrated increased anticancer activity in several cancer cell lines. Pharmacokinetic studies in male rats that were orally administered MCNs showed a 3.2-fold increase in the area under the

Nanofibers for drug delivery – incorporation and release of model molecules, influence of molecular weight and polymer structure

• Jakub Hrib,
• Jakub Sirc,
• Radka Hobzova,
• Zuzana Hampejsova,
• Zuzana Bosakova,
• Marcela Munzarova and
• Jiri Michalek

Beilstein J. Nanotechnol. 2015, 6, 1939–1945, doi:10.3762/bjnano.6.198

• ; nanofibrous carriers; needle-free electrospinning; release kinetics; Introduction To date, numerous drug delivery systems have been developed, such as hydrogels that carry drugs or highly sophisticated electronic microchips [1][2]. The required release rates of the therapeutic agents depend on the medicinal

• concluded that the release kinetics are given by effects discussed above. Despite attempts to ensure the similar nanofibrous structures, the varied morphology may be also responsible for the variation in the PEG release rate. The release of model molecules directly correlated with the specific surface areas

• polymers and PEG of various molecular weights leads to materials with significantly different release kinetics of PEGs. These basic findings on relationships between PEG size and polymer structure on release kinetics were done in respect that even PEG serves as additive compound it has main effect on the

Protein corona – from molecular adsorption to physiological complexity

• Lennart Treuel,
• Dominic Docter,
• Michael Maskos and
• Roland H. Stauber

Beilstein J. Nanotechnol. 2015, 6, 857–873, doi:10.3762/bjnano.6.88

• consequence, the delicate interplay between the relative timescales of particle transport and dissolution/release kinetics can well govern NP toxicity. While this factor further complicates a fundamental understanding of NP toxicity, the right time-scale ratio of the participating effects can be a critically

Hematopoietic and mesenchymal stem cells: polymeric nanoparticle uptake and lineage differentiation

• Ivonne Brüstle,
• Thomas Simmet,
• Gerd Ulrich Nienhaus,
• Katharina Landfester and
• Volker Mailänder

Beilstein J. Nanotechnol. 2015, 6, 383–395, doi:10.3762/bjnano.6.38

• intracellular depot of a drug or a nucleic acid construct with slow release kinetics. Thus, the intended nanoparticles should be tested for toxicity and the nanomaterial as a carrier ideally should not influence cellular functions itself, that is, only the payload should exert such an effect. Once introduced

Release behaviour and toxicity evaluation of levodopa from carboxylated single-walled carbon nanotubes

• Julia M. Tan,
• Jhi Biau Foo,
• Sharida Fakurazi and
• Mohd Zobir Hussein

Beilstein J. Nanotechnol. 2015, 6, 243–253, doi:10.3762/bjnano.6.23

• exhibited favourable, slow, sustained-release characteristics as a drug carrier with a release period over more than 20 h. The results obtained from the drug release studies of LD at different pH values showed that the LD-loaded nanohybrid is pH activated. The release kinetics of LD from SWCNT–COOH were

• therapeutic effect [26] and may benefit the treatment of PD. Release kinetics of LD To further analyse the release kinetics of LD from the SWCNT–COOH nanocarrier, pseudo-first-order (Equation 1), pseudo-second-order (Equation 2) and a parabolic diffusion equation (Equation 3) were adopted [3][27][28] as

Liquid fuel cells

• Grigorii L. Soloveichik

Beilstein J. Nanotechnol. 2014, 5, 1399–1418, doi:10.3762/bjnano.5.153

• ]. Hydrogen can be reversibly stored in metallic hydrides, e.g., intermetallic phases AB5 and AB3 [16], or complex hydrides, e.g., metal borohydrides M(BH4)n [17]. However, good hydrogen release kinetics and reversibility are inversely correlated with the storage capacity. Dehydrogenation of metal hydrides

Nanodiamond-DGEA peptide conjugates for enhanced delivery of doxorubicin to prostate cancer

• Amanee D Salaam,
• Patrick Hwang,
• Roberus McIntosh,
• Hadiyah N Green,
• Ho-Wook Jun and
• Derrick Dean

Beilstein J. Nanotechnol. 2014, 5, 937–945, doi:10.3762/bjnano.5.107

• drug concentrations, DOX efficacy was enhanced. The quantitative analysis of DOX release kinetics and cellular internalization are limitations of this study and should be the subject of future studies. Conclusion In this study, a novel targeted drug delivery system consisting of NDs (drug delivery

Injection of ligand-free gold and silver nanoparticles into murine embryos does not impact pre-implantation development

• Ulrike Taylor,
• Wiebke Garrels,
• Annette Barchanski,
• Svea Peterson,
• Laszlo Sajti,
• Andrea Lucas-Hahn,
• Lisa Gamrad,
• Ulrich Baulain,
• Sabine Klein,
• Wilfried A. Kues,
• Stephan Barcikowski and
• Detlef Rath

Beilstein J. Nanotechnol. 2014, 5, 677–688, doi:10.3762/bjnano.5.80

• µg/mL] AgNP dispersion was added to a blastomere with a volume of 90 pL [56]. The chosen concentration of Ag+-ions was approximated based on previously reported ion release kinetics of silver colloids in aqueous solution [57]. Control co-incubations of embryos with equimolar KNO3 showed no effect

Near-infrared dye loaded polymeric nanoparticles for cancer imaging and therapy and cellular response after laser-induced heating

• Tingjun Lei,
• Alicia Fernandez-Fernandez,
• Romila Manchanda,
• Yen-Chih Huang and
• Anthony J. McGoron

Beilstein J. Nanotechnol. 2014, 5, 313–322, doi:10.3762/bjnano.5.35

• compared to the free form [24]. Our release kinetics and pharmacokinetics study results [24] seem to indicate that the NP formulation stabilizes IR820, protecting it from degradation and allowing for longer detection windows. Discussion The MW of PGMD polymer is 3000 Da, which is expected for polymers